Zuckerbrot-Schuldenfrei, Miriam
Raphael, Ari
Zilberberg, Alona
Efroni, Sol
Funding for this research was provided by:
Israel Cancer Research Fund (829965)
Israel Cancer Research Fund (829965)
ISF (582/19)
ISF (582/19)
VATAT
Article History
Received: 20 December 2024
Accepted: 27 July 2025
First Online: 8 August 2025
Competing interests
: Alona Zilberberg and Sol Efroni are the founders of Clonal. Work in this manuscript is associated with US Provisional Patent Application No. PCT/IL2023/051098, Title: Methods for Detection of Breast Cancer, 24-Oct-23. All other authors declare no competing interests.